ASJ Study Puts the Risk of Death From Breast Implant-Associated Anaplastic Large Cell Lymphoma Into Plain Perspective for Patients
August 23, 2017
August 23, 2017
NEW YORK, Aug. 23 -- The American Society for Aesthetic Plastic Surgery issued the following news release:
Findings from a recent study published in the Aesthetic Surgery Journal showed that the risk of dying from breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is 0.4, based on a micromort analysis, a unique tool measuring relative risk of activities, and exposures, defined by Ronald Howard in 1979 as 1 micromort = 1:1 million chance of death. The study will help . . .
Findings from a recent study published in the Aesthetic Surgery Journal showed that the risk of dying from breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is 0.4, based on a micromort analysis, a unique tool measuring relative risk of activities, and exposures, defined by Ronald Howard in 1979 as 1 micromort = 1:1 million chance of death. The study will help . . .